Literature DB >> 32038926

Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain.

Jose M Pacheco1, Drew Moghanaki2,3.   

Abstract

Entities:  

Year:  2019        PMID： 32038926      PMCID： PMC6987340          DOI： 10.21037/tlcr.2019.06.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  20 in total

1.  Staging the Metastatic Spectrum Through Integration of Clinical and Molecular Features.

Authors:  Corey C Foster; Sean P Pitroda; Ralph R Weichselbaum
Journal:  J Clin Oncol       Date:  2019-04-02       Impact factor: 44.544

2.  The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis-From Conception to Treatment.

Authors:  Ralph R Weichselbaum
Journal:  J Clin Oncol       Date:  2018-09-27       Impact factor: 44.544

3.  Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

Authors:  Jason J Luke; Jeffrey M Lemons; Theodore G Karrison; Sean P Pitroda; James M Melotek; Yuanyuan Zha; Hania A Al-Hallaq; Ainhoa Arina; Nikolai N Khodarev; Linda Janisch; Paul Chang; Jyoti D Patel; Gini F Fleming; John Moroney; Manish R Sharma; Julia R White; Mark J Ratain; Thomas F Gajewski; Ralph R Weichselbaum; Steven J Chmura
Journal:  J Clin Oncol       Date:  2018-02-13       Impact factor: 44.544

4.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

5.  Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

Authors:  Liufu Deng; Hua Liang; Byron Burnette; Michael Beckett; Thomas Darga; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

6.  Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.

Authors:  Michael D Hasselle; Daniel J Haraf; Kyle E Rusthoven; Daniel W Golden; Ravi Salgia; Victoria M Villaflor; Niket Shah; Philip C Hoffman; Steven J Chmura; Philip P Connell; Everett E Vokes; Ralph R Weichselbaum; Joseph K Salama
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

7.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Authors:  Michael T Milano; Alan W Katz; Hong Zhang; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-13       Impact factor: 7.038

8.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

9.  Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.

Authors:  Karynsa Cetin; David S Ettinger; Yong-Jiang Hei; Cynthia D O'Malley
Journal:  Clin Epidemiol       Date:  2011-04-28       Impact factor: 4.790

10.  Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.

Authors:  Sean P Pitroda; Nikolai N Khodarev; Lei Huang; Abhineet Uppal; Sean C Wightman; Sabha Ganai; Nora Joseph; Jason Pitt; Miguel Brown; Martin Forde; Kathy Mangold; Lai Xue; Christopher Weber; Jeremy P Segal; Sabah Kadri; Melinda E Stack; Sajid Khan; Philip Paty; Karen Kaul; Jorge Andrade; Kevin P White; Mark Talamonti; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum
Journal:  Nat Commun       Date:  2018-05-04       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.